The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKGP.L Regulatory News (KGP)

  • There is currently no data for KGP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

16 Nov 2020 07:00

RNS Number : 3426F
Kingspan Group PLC
16 November 2020
 

Kingspan Group Plc

Trading Update

 

16 November 2020

 

Kingspan Group plc, the global leader in high performance insulation and building envelope solutions, today issues a Trading Update for the period to 30 September 2020.

Sales in the nine month period to 30 September were €3.27bn, down 5% on the same period in the prior year with sales growth of 1% in the third quarter. Underlying sales (pre currency and acquisitions) were down 10% in the year to date and by 6% in the third quarter.

 

Insulated Panel sales decreased by 6% in the first nine months and by 3% in the third quarter. Underlying sales were down 10% year to date and down 7% in the third quarter. Sales and order intake activity in a number of key markets were positive during the third quarter. Notably, France and Germany have been busy whilst the UK has been softer albeit with a more recent improvement in order intake. In the Americas the US has been solid overall, Canada has been weak and Latin America has seen decent momentum. In the third quarter an element of price deflation was experienced due to a reduction in raw material prices. Overall, the global Insulated Panel's backlog was up 10% in value as at 30 September versus the same point last year.

 

Insulation Board sales in the first nine months were down 14% and down 5% in the third quarter. Volumes improved through the third quarter with raw material related price deflation in the earlier part of the period partially offsetting this. Sales in the UK, Ireland and much of Continental Europe performed well through the third quarter. The Asia Pacific region consolidated the progress seen in the first half whilst the Middle East has been a more challenging environment. Activity in the US was positive through the third quarter.

 

Light & Air sales in the first nine months were up 30% and up 46% in the third quarter. Underlying sales were down 9% year to date and down 8% in the third quarter. European sales overall were solid in the third quarter although the US was sluggish versus a demanding comparative. The Colt acquisition, completed in April, has continued to integrate and perform well. Overall, the project pipeline is encouraging reflecting the breadth of the division's expanded category offering.

 

Data & Flooring sales in the first nine months were up 6% and up 7% in the third quarter. Underlying sales were behind by 5% in the first nine months and were ahead by 3% in the third quarter. Datacentre demand globally is robust, offsetting a weaker office market.

 

Water and Energy sales in the first nine months decreased by 5% and increased by 4% in the third quarter with waste water and rain water harvesting solutions notable positives.

 

Net debt at the end of September 2020 was €312.0m with working capital somewhat lower than is typical, although it is expected to normalise in the coming months.

 

Overall, our end markets are in reasonable shape bearing in mind the uncertain and evolving backdrop. In this environment it is difficult to see too far ahead and trading patterns can evolve quickly. Our raw material costs are on the rise at present and, with the customary lag anticipated, a challenging recovery effort is underway. Trading in the fourth quarter to date has been strong, helped to an extent by accelerated demand in the expectation of inflation led price increases in the coming months. Whilst conscious that much of the seasonally variable fourth quarter is still at play, in what is an untypical year, we expect to deliver a full year trading profit marginally ahead of 2019.

 

 

 

For further information contact:

 

Gene Murtagh, Chief Executive Officer Tel: +353 (0) 42 9698000

 

Geoff Doherty, Chief Financial Officer Tel: +353 (0) 42 9698000

 

Douglas Keatinge, Murray Consultants Tel: +353 (0) 1 4980300

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTVXLFFBFLEFBX
Date   Source Headline
18th Aug 20237:05 amRNSDelisting from the London Stock Exchange
18th Aug 20237:00 amRNSHalf-year Report
20th Jul 202311:37 amRNSResult of EGM
20th Jul 20239:56 amRNSHolding(s) in Company
18th Jul 20237:00 amRNSAcquisition
11th Jul 20237:00 amRNSTrading Update
3rd Jul 20232:40 pmRNSBlock listing Interim Review
3rd Jul 20232:34 pmRNSTotal Voting Rights
30th Jun 20234:54 pmRNSHolding(s) in Company
26th Jun 20232:00 pmRNSCircular and Notice of EGM
23rd Jun 20234:08 pmRNSHolding(s) in Company
14th Jun 20234:56 pmRNSHolding(s) in Company
14th Jun 20234:54 pmRNSHolding(s) in Company
1st Jun 20235:25 pmRNSTotal Voting Rights
2nd May 20235:09 pmRNSTotal Voting Rights
28th Apr 20234:07 pmRNSDirectorate Change
28th Apr 20234:00 pmRNSResult of AGM
28th Apr 20237:00 amRNSTrading Statement
3rd Apr 20234:40 pmRNSTotal Voting Rights
30th Mar 20239:00 amRNSDirector/PDMR Shareholding
21st Mar 20235:24 pmRNSDirector/PDMR Shareholding
20th Mar 20235:29 pmRNSHolding(s) in Company
20th Mar 20235:28 pmRNSHolding(s) in Company
16th Mar 20234:29 pmRNSHolding(s) in Company
16th Mar 20232:05 pmRNSNotice of AGM
1st Mar 20234:28 pmRNSTotal Voting Rights
1st Mar 20233:33 pmRNSHolding(s) in Company
1st Mar 202312:39 pmRNSDirector/PDMR Shareholding
28th Feb 20231:11 pmRNSDirector/PDMR Shareholding
24th Feb 20231:09 pmRNSHolding(s) in Company
23rd Feb 20234:57 pmRNSAnnual Financial Report
23rd Feb 20239:00 amRNSDirector/PDMR Shareholding
21st Feb 20235:34 pmRNSDirector/PDMR Shareholding
21st Feb 20235:28 pmRNSDirector/PDMR Shareholding
17th Feb 20237:30 amRNSDirectorate Change
17th Feb 20237:00 amRNSFinal Results
13th Feb 20236:02 pmRNSHolding(s) in Company
10th Feb 20233:00 pmRNSHolding(s) in Company
8th Feb 20234:35 pmRNSPrice Monitoring Extension
3rd Feb 20232:12 pmRNSHolding(s) in Company
2nd Feb 20234:27 pmRNSHolding(s) in Company
30th Jan 20232:48 pmRNSHolding(s) in Company
26th Jan 20234:40 pmRNSSecond Price Monitoring Extn
26th Jan 20234:35 pmRNSPrice Monitoring Extension
25th Jan 20234:05 pmRNSHolding(s) in Company
19th Jan 20237:00 amRNSHolding(s) in Company
17th Jan 20234:40 pmRNSHolding(s) in Company
3rd Jan 20239:05 amRNSBlock listing Interim Review
3rd Jan 20239:00 amRNSTotal Voting Rights
21st Dec 20224:14 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.